Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion

Vascular Pharmacology

Volumn 48, Issue 2-3, 2008, Pages 109-114

  García Villalón, Angel Luis ^a   Amezquita, Yesika María ^a   Monge, Luis ^a   Fernández, Nuria ^a   Salcedo, Adely ^a   Diéguez, Godofredo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

5 hydroxytryptamine; ETB receptors; nitric oxide endothelin ETA receptors; Perfused heart; U46619

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; MECLOFENAMIC ACID; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CORONARY ARTERY CONSTRICTION; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CORONARY VESSELS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIN-1; ENZYME INHIBITORS; MALE; MECLOFENAMIC ACID; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PERFUSION; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SEROTONIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 40149084453     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.01.003     Document Type: Article

References (34)

1. Bauersachs J., Fraccarollo D., Galuppo P., Widder J., and Ertl G. Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure. Cardiovasc. Res. 47 (2000) 142-149
2. Brunner F., du Toit E.F., and Opie L.H. Endothelin release during ischemia and reperfusion of isolated perfused rat heart. J. Mol. Cell. Cardiol. 24 (1992) 1291-1305
3. De Clerk F., and Janssen P.A. 5-hydroxytryptamine and thromboxane A2 in ischemic heart disease. Blood Coagul. Fibrinolysis 1 (1990) 201-209
4. Edwards J.D., McGregor P.E., Dovgan P.S., and Agrawal D.K. Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries. Life Sci. 57 (1995) 225-234
5. Eskesen K., and Edvinsson L. Upregulation of endothelin ETB receptor-mediated vasoconstriction in rat coronary artery after organ culture. Eur. J. Pharmacol. 539 (2006) 192-194
6. Fernández N., Martínez M.A., Climent B., García-Villalón A.L., Monge L., Sanz E., and Diéguez G. In vivo coronary effects of endothelin-1 after ischemia-reperfusion: role of nitric oxide and prostanoids. Eur. J. Pharmacol. 481 (2003) 109-117
7. García-Villalón A.L., Padilla J., Fernández N., Monge L., Gómez B., and Diéguez G. Role of endothelin receptors, calcium and nitric oxide in the potentiation by endothelin-1 of the sympathetic contraction of rabbit ear artery during cooling. Br. J. Pharmacol. 12 (1997) 1659-1664
8. García-Villalón A.L., Monge L., Fernández N., Sánchez M.A., Martínez M.A., Gómez B., and Diéguez G. Basal inhibitory action of endogenous endothelin on the sympathetic contraction in the isolated rat tail artery. Eur. J. Pharmacol. 384 (1999) 163-167
9. García-Villalón A.L., Monge L., Fernández N., Sánchez M.A., Martínez M.A., Gómez B., and Diéguez G. Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats. Cardiovasc. Res. 45 (2000) 463-469
10. García-Villalón A.L., Amezquita Y.M., Monge L., Fernández N., Climent B., Sánchez A., and Diéguez G. Effect of ischemia duration and nitric oxide on coronary vasoconstriction after ischemia-reperfusion. Eur. J. Pharmacol. 509 (2005) 165-170
11. Gonon A.T., Gourine A.V., and Pernow J. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production. J. Cardiovasc. Pharmacol. 36 (2000) 405-412
12. Gossl M., Mitchell A., Lerman A., Opazo Saez A., Schafers R.F., Erbel R., Philipp T., and Wenzel R.R. Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II. J. Hypertens. 22 (2004) 1909-1916
13. Hempelmann R.G., Pradel R.H., Mehdorn H.M., and Ziegler A. Threshold concentrations of endothelin-1: the effects on contractions induced by 5-hydroxytryptamine in isolated rat and cerebral and mesenteric arteries. Pharmacol. Toxicol. 85 (1999) 115-122
14. Henrion D., and Laher I. Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta. Hypertension 22 (1993) 78-83
15. Jen C.J., Huang T.Y., Chen H.I., Wing L.Y., Lin M.T., Wu H.L., and Chang W.C. Regional differences in prostaglandin production rates among porcine intrathoracic vessels. Prostaglandins 47 (1994) 109-122
16. Muramatsu K., Tomoike H., Ohara Y., Egashira S., and Nakamura M. Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs. Heart Vessels 6 (1991) 191-196
17. Nakayama K., Ishigai Y., Uchida H., and Tanaka Y. Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig. Br. J. Pharmacol. 104 (1991) 978-986
18. Obara K., Hata S., Sato K., Koide M., Ishii K., and Nakayama K. Contractile potentiation by endothelin-1 involves protein kinase C-delta activity in the porcine coronary artery. Jpn. J. Physiol. 49 (1999) 175-183
19. Padilla J., García-Villalón A.L., Monge L., García J.L., Fernández N., Gómez B., and Diéguez G. Peptidergic modulation of the sympathetic contraction in the rabbit ear artery: effects of temperature. Br. J. Pharmacol. 121 (1997) 21-28
20. Pernow J., and Wang Q.-D. Endothelin in myocardial ischemia and reperfusion. Cardiovasc. Res. 33 (1997) 518-526
21. Saldeen T.G., Saldeen P., Nichols W.W., Lawson D.L., Nicolini F.A., and Mehta J.L. Increased production of thromboxane A2 by coronary arteries after thrombolysis. Am. Heart J. 125 (1993) 277-284
22. Sanz E., Fernández N., Monge L., Martínez M.A., Climent B., Diéguez G., and García-Villalón A.L. Effects of diabetes on the vascular response to nitric oxide and constrictor prostanoids: gender and regional differences. Life Sci. 72 (2003) 1537-1547
23. Schiffrin E.L., and Touyz R.M. Vascular biology of endothelin. J. Cardiovasc. Pharmacol. 32 Suppl 3 (1998) S2-S13
24. Stewart D.J., Kubac G., Costello K.B., and Cernacek P. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18 (1991) 38-43
25. Sutherland F.J., and Hearse D.J. The isolated blood and perfusion fluid perfused heart. Pharmacol. Res. 41 (2000) 613-627
26. Thompson M., Westwick J., and Woodward B. Responses to endothelins-1, -2, and -3 and sarafotoxin 6c after ischemia/reperfusion in isolated perfused rat heart: role of vasodilator loss. J. Cardiovasc. Pharmacol. 25 (1995) 156-162
27. Toyo-oka T., Aizawa T., Suzuki N., Hirata Y., Miyauchi T., Shin W.S., Yanagisawa M., Masaki T., and Sugimoto T. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83 (1991) 701-703
28. Vila J.M., Medina P., Segarra G., Aldasoro M., Nogera I., and Lluch S. Endothelin-1-induced potentiation of adrenergic responses in the rabbit pulmonary artery: role of thromboxane A(2). Eur. J. Pharmacol. 413 (2001) 247-254
29. Vitola J.V., Forman M.B., Holsinger J.P., Kawana M., Atkinson J.B., Quertermous T., Jackson E.K., and Murray J.J. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists. J. Cardiovasc. Pharmacol. 28 (1996) 774-783
30. Wang Q.-D., Uriuda Y., Pernow J., Hemsen A., Sjöquist P.-O., and Ryden L. Myocardial release of endothelin (ET) and enhanced ETA receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs. J. Cardiovasc. Pharmacol. 26 (1995) 770-776
31. Wang Q.-D., Pernow J., Sjöquist P.-O., and Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc. Res. 55 (2002) 25-37
32. Watts J.A., Chapat S., Johnson D.E., Janis D.E., and Janis R.A. Effects of nosoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts. J. Cardiovasc. Pharmacol. 19 (1992) 929-936
33. Yang Z.H., Richard V., von Segeser L., Bauer E., Stulz P., Turina M., and Luscher T.F. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?. Circulation 82 (1990) 188-195
34. Zerrouk A., Champeroux P., Safar M., and Brisac A.M. Role of endothelium in the endothelin-1 mediated potentiation of the norepinephrine response in the aorta of hypertensive rats. J. Hypertens. 5 (1997) 1101-1111